Yu Zhang

机构：Central South University, University of Electronic Science and Technology of China, Xuzhou Medical College, Wenzhou Medical University, Huangshan University, Mianyang Central Hospital, Ruian People's Hospital, Hunan Cancer Hospital, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Zhujiang Hospital, Second Affiliated Hospital of Nanjing Medical University, Guangdong Academy of Medical Sciences, Changzhou No.2 People's Hospital, Wenzhou City People's Hospital, Guangdong Provincial People's Hospital, Fu Wai Hospital, Nanjing Medical University · ORCID：0000-0003-2274-429X

发表论文 77 篇 · 总被引 1683 次 · h-index 19

代表论文

• Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer (2024 · JAMA · 被引 359)
• Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant (2024 · JAMA · 被引 186)
• Integrative single-cell analysis of human colorectal cancer reveals patient stratification with distinct immune evasion mechanisms (2024 · Nature Cancer · 被引 133)
• Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC (2025 · New England Journal of Medicine · 被引 60)
• Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial (2025 · The Lancet · 被引 51)
• Blockade of Hepatocyte PCSK9 Ameliorates Hepatic Ischemia-Reperfusion Injury by Promoting Pink1-Parkin–Mediated Mitophagy (2023 · Cellular and Molecular Gastroenterology and Hepatology · 被引 39)